318 related articles for article (PubMed ID: 7878905)
1. Early endocrine pancreas graft function and outcome after simultaneous pancreas-kidney transplantation.
Troppmann C; Benedetti E; Gruessner AC; Papalois BE; Sutherland DE; Gruessner RW
Transplant Proc; 1995 Feb; 27(1):1340-1. PubMed ID: 7878905
[No Abstract] [Full Text] [Related]
2. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
[No Abstract] [Full Text] [Related]
3. Is HLA matching worthwhile in pancreatic transplantation?
Hopt UT; Büsing M; Schareck W; Pfeffer F; Irkin I; Becker HD
Transplant Proc; 1992 Jun; 24(3):909-10. PubMed ID: 1604664
[No Abstract] [Full Text] [Related]
4. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D
Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868
[No Abstract] [Full Text] [Related]
5. Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
Cantarovich D; Dantal J; Hourmant M; Baatard R; Paineau J; Murat A; Soulillou JP
Transplant Proc; 1992 Jun; 24(3):890-1. PubMed ID: 1604657
[No Abstract] [Full Text] [Related]
6. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
[No Abstract] [Full Text] [Related]
7. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO
Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629
[No Abstract] [Full Text] [Related]
8. [Long-term results in pancreas transplantation in diabetes in the pre-cyclosporin era].
Largiadèr F
Schweiz Med Wochenschr; 1996 Aug; 126(34):1433-6. PubMed ID: 8848705
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.
Osei K; Henry M; Ferguson R
Transplant Proc; 1994 Apr; 26(2):480-2. PubMed ID: 8171515
[No Abstract] [Full Text] [Related]
10. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
Ketel BL; Turton-Weeks S; Reed K; Barone GW
Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
[No Abstract] [Full Text] [Related]
11. Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
Cantarovich D; Hourmant M; Dantal J; Baatard R; Le Mauff B; Jacques Y; Paineau J; Murat A; Soulillou JP
Transplant Proc; 1993 Feb; 25(1 Pt 2):1366. PubMed ID: 8442143
[No Abstract] [Full Text] [Related]
12. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
[No Abstract] [Full Text] [Related]
13. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
[No Abstract] [Full Text] [Related]
14. Probability of retaining endocrine function (insulin independence) after definitive loss of exocrine function in bladder-drained pancreas transplants.
Barrou B; Barrou Z; Gruessner A; Munns KC; Gruessner RW; Sutherland DE
Transplant Proc; 1994 Apr; 26(2):473-4. PubMed ID: 8171511
[No Abstract] [Full Text] [Related]
15. Pancreas-kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy.
Sugitani A; Ishibashi M; Ito T; Nakajima K; Matsuno N; Kanazawa Y; Motoyama K; Yamamoto H; Inoue S; Ota M; Yoshida JI; Tanaka M
Transplant Proc; 2004 Mar; 36(2 Suppl):356S-361S. PubMed ID: 15041368
[TBL] [Abstract][Full Text] [Related]
16. Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant?
Cheung AH; Matas AJ; Gruessner RG; Dunn DL; Moudry-Munns KC; Najarian JS; Sutherland DE
Transplant Proc; 1993 Feb; 25(1 Pt 2):1184-5. PubMed ID: 8442081
[No Abstract] [Full Text] [Related]
17. Long-term results after simultaneous pancreas-kidney transplantation using donors aged 45 years or older.
Schenker P; Wunsch A; Ertas N; Schaeffer M; Rump LC; Viebahn R; Vonend O
Transplant Proc; 2008 May; 40(4):923-6. PubMed ID: 18555080
[TBL] [Abstract][Full Text] [Related]
18. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
19. Assessment of donor and recipient risk factors on pancreas transplant outcome.
Gruessner RW; Troppmann C; Barrou B; Dunn DL; Moudry-Munns KC; Najarian JS; Sutherland DE; Gruessner AC
Transplant Proc; 1994 Apr; 26(2):437-8. PubMed ID: 8171491
[No Abstract] [Full Text] [Related]
20. Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure?
Stegall MD; Ploeg RJ; Pirsch JD; Sasaki TM; D'Alessandro AM; Knechtle SJ; Belzer FO; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):230-2. PubMed ID: 8438281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
